Sanofi SA
XETRA:SNW
Sanofi SA
XETRA:SNW
Price:
80.18
EUR
-0.34%
Market Cap:
€100.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sanofi SA
XETRA:SNW
|
FR |
|
Black Bear Minerals Ltd
OTC:BKBMF
|
AU |
|
V
|
Virtuix Holdings Inc
NASDAQ:VTIX
|
US |
|
E
|
Element Nutritional Sciences Inc
CNSX:ELMT
|
CA |
|
Bullet Blockchain Inc
OTC:BULT
|
US |
|
O
|
OTG Acquisition I Corp
NASDAQ:OTGA
|
US |
|
Impac Mortgage Holdings Inc
OTC:IMPM
|
US |
|
Virtus Investment Partners Inc
NYSE:VRTS
|
US |
|
Lion Metal Works Tbk PT
IDX:LION
|
ID |
|
Mirle Automation Corp
TWSE:2464
|
TW |
|
W
|
Western Forest Products Inc
SWB:NWF
|
CA |
|
Lake Winn Resources Corp
XTSX:LWR
|
CA |
|
F
|
Friday's Dog Holdings Inc
XTSX:DOGS
|
CA |
|
San-Ai Obbli Co Ltd
TSE:8097
|
JP |
|
Giglio Group SpA
MIL:GG
|
IT |
|
Taylor Wimpey PLC
OTC:TWODY
|
UK |
|
Weed Inc
OTC:BUDZ
|
US |
|
Solstice Gold Corp
XTSX:SGC
|
CA |
|
Odyssey Semiconductor Technologies Inc
OTC:ODII
|
US |
|
M
|
Modiv Inc
NYSE:MDV
|
US |
|
A
|
Australian Vanadium Ltd
OTC:ATVVF
|
AU |
|
H
|
Hera SpA
XBER:HE9
|
IT |
|
Founding Construction Development Co Ltd
TWSE:5533
|
TW |
|
NPO Nauka PAO
MOEX:NAUK
|
RU |
Multiples-Based Value
The
Multiples-Based Value for
Sanofi SA (SNW)
under the Base Case is
hidden
EUR.
Compared with the current market price of 80.18 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SNW Multiples-Based Value
LOCKED
Multiples Across Competitors
SNW Competitors Multiples
Sanofi SA Competitors
Sanofi SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
XETRA:SNW
|
96.9B EUR | 2.1 | 12.4 | 10.4 | 10.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
887.6B USD | 13.6 | 43 | 29 | 31 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.2B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.2B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.5 | 11.6 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.5B USD | 4.6 | 16.5 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
234.4B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.1B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118B USD | 2.5 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
